• Banner reading Nature Awards Microbiome Accelerator

    The Accelerator will identify microbiome research with the potential to transform human health outcomes. Four carefully chosen applicants will be awarded $10,000 and gain entry to our immersive residential program that provides the training, mentorship and connections to translate groundbreaking research for maximum impact. The deadline for applications is 24 June 2024.

  • Logo

    On the second episode of our new podcast series, Associate Editor Cláudia Vilhena talks with co-authors Siyu He, Yinuo Jin and Lingting Shi about Starfysh, a computational toolbox combining spatial transcriptomics and histology data. They dig into the layers of Starfysh and its relevance for cancer research, and share the struggles of peer review and the wonders of collaborative work.

  • Illustration of female doctor and patient talking about female health

    Biopharma Dealmakers: For centuries, women’s health has been neglected across science, medicine and technology. A new report from the World Economic Forum suggests tackling this could unlock a $1 trillion economic boost with the potential to change the lives of 3.9 billion women.

Nature Biotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


lona Nagy/Getty

Navigating the vaccines landscape

We explore the latest developments in the vaccines field, through our editorial feature and showcase of companies.


Nature Careers

Science jobs